Compounds > evans blue
Page last updated: 2024-08-21

evans blue and Neoplasm Metastasis

evans blue has been researched along with Neoplasm Metastasis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Akbarian, R; Fattahi, K; Ghodsirad, MA; Javanmard, B; Kaghazchi, F; Pirayesh, E; Tavakoli, M1
Do, J; Doyle, TC; Foster, D; Renier, C; Rosenblum, S; Tse, V; Vogel, H; Wapnir, I1
Ali, IU; Chen, X; Huang, P; Jacobson, O; Kiesewetter, DO; Lang, L; Niu, G; Teng, G; Wang, Y; Wang, Z1
Bougnoux, P; Champeroux, P; Chevalier, S; Goupille, C; Kornfeld, S; Lebeau, J; Mahéo, K; Martel, E; Maurin, A; Pinet, A; Richard, S; Tranquart, F; Vibet, S1
Bruns, OT; Freund, B; Heine, M; Hohenberg, H; Ittrich, H; Masslo, C; Nielsen, P; Nollau, P; Peldschus, K; Reimer, R; Schumacher, U1

Other Studies

5 other study(ies) available for evans blue and Neoplasm Metastasis

ArticleYear
Diagnostic Utility of Lutetium-177 (Lu 177) Prostate-Specific Membrane Antigen (PSMA) Scintigraphy In Prostate Cancer Patients With PSA Rise And Negative Conventional Imaging.
    Urology journal, 2020, 06-23, Volume: 17, Issue:4

    Topics: Aged; Aged, 80 and over; Dipeptides; Evans Blue; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

2020
Ex vivo Evans blue assessment of the blood brain barrier in three breast cancer brain metastasis models.
    Breast cancer research and treatment, 2014, Volume: 144, Issue:1

    Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Coloring Agents; Evans Blue; Female; Humans; Immunohistochemistry; Mice; Mice, Nude; Neoplasm Metastasis; Xenograft Model Antitumor Assays

2014
In vivo albumin labeling and lymphatic imaging.
    Proceedings of the National Academy of Sciences of the United States of America, 2015, Jan-06, Volume: 112, Issue:1

    Topics: Albumins; Aluminum Compounds; Animals; Diagnostic Imaging; Evans Blue; Fluorescence; Fluorides; Fluorine Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Hindlimb; Image Processing, Computer-Assisted; Inflammation; Luminescent Measurements; Lymph Nodes; Lymphatic Vessels; Mice, Inbred BALB C; Multimodal Imaging; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Staining and Labeling

2015
Reducing endothelial NOS activation and interstitial fluid pressure with n-3 PUFA offset tumor chemoresistance.
    Carcinogenesis, 2012, Volume: 33, Issue:2

    Topics: Animals; Cell Movement; Cells, Cultured; Coloring Agents; Disease Progression; Docetaxel; Docosahexaenoic Acids; Drug Resistance, Neoplasm; Eicosapentaenoic Acid; Endothelial Cells; Evans Blue; Extracellular Fluid; Fatty Acids, Omega-3; Female; Human Umbilical Vein Endothelial Cells; Humans; Mammary Neoplasms, Animal; Neoplasm Metastasis; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Permeability; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Taxoids; Vascular Endothelial Growth Factor A

2012
Investigations on the usefulness of CEACAMs as potential imaging targets for molecular imaging purposes.
    PloS one, 2011, Volume: 6, Issue:12

    Topics: Albumins; Animals; Antigens, CD; Biomarkers; Caco-2 Cells; Carcinoembryonic Antigen; Cell Adhesion Molecules; Cell Line, Tumor; Evans Blue; Female; Humans; Immunohistochemistry; Lymphatic Vessels; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Molecular Imaging; Neoplasm Metastasis; Neoplasm Transplantation; RNA, Messenger

2011